From Wikipedia, the free encyclopedia

WHO Expert Committee on Leprosy is constituted by World Health Organization to study the worldwide progress of Leprosy.

Reports

  • First report published as Technical Report Series No. 71 in 1954.
  • Second report published as Technical Report Series No. 189 in 1960. [1]
  • Third report published as Technical Report Series No. 319 in 1966.
  • Fourth report published as Technical Report Series No. 459 in 1970.
  • Fifth report published as Technical Report Series No. 607 in 1977. [2]
  • Sixth report published as Technical Report Series No. 768 in 1988.
  • Seventh report published as Technical Report Series No. 874 in 1998. [3] They concluded that a single dose of a combination of rifampicin, ofloxacin and minocycline is an acceptable and cost-effective alternative regimen for the treatment of single-lesion paucibacillary leprosy and the duration of the standard regimen for multibacillary leprosy could be shortened to 12 months.
  • Eighth report published as ISBN  978-92-4-120968-7 in 2012.

References

  1. ^ Expert Committee on Leprosy (Open Library). openlibrary.org. 1960. OL  22389969M. Retrieved 2015-01-01.
  2. ^ "WHO Technical Report Series No. 607" (PDF). whqlibdoc.who.int. Retrieved 2015-01-01.
  3. ^ WHO Expert Committee on Leprosy (1998). WHO Expert Committee on Leprosy: Seventh Report. World Health Organization. ISBN  9789241208741. Retrieved 2015-01-01.
Retrieved from " https://en.wikipedia.org/?title=WHO_Expert_Committee_on_Leprosy&oldid=1198953681"